Statin-induced necrotizing autoimmune myopathy (SINAM) is an exceptionally rare yet devastating complication of statin therapy that can occur at any time after initiation. It should be considered in patients who develop proximal muscle weakness and marked elevated creatine phosphokinase while taking statin therapy. (Level of Difficulty: Beginner.)
No takes yet. Share an insight, caveat, or question.
Gawey et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: